BioSpace News Archive

How to Deal with a Know-It-All in the Workplace

Have you ever had a great idea shot down by a “Know-it-all” at work? Maybe they didn’t even give you the chance to fully explain your thoughts or position.

October 4, 2018
·
3 min read
·
Porschia Parker-Griffin
Business

Arrowhead Goes All in With J&J to Develop Hep B Drug for $3.7B

Arrowhead announced a deal with Johnson & Johnson that could conceivably be worth over $3.7 billion, with J&J agreeing to pick up a minor stake in the company, including the task of cultivating and promoting its ARO-HBV Hepatitis B drug.

October 4, 2018
·
3 min read
·
Elizabeth Glasure
Drug Development

It’s Flu Season! Genentech’s Investigational Medicine Continues to Show Efficacy

New late-stage data released by South San Francisco-based Genentech shows treatment with baloxavir marboxil significantly reduced the time to improvement of influenza symptoms versus placebo in patients who are at high risk of serious complications from the flu.

October 4, 2018
·
2 min read
·
Alex Keown
Genetown

In Small Patient Group, Sarepta’s DMD Gene Therapy Gives Some Hope

Sarepta Therapeutics’ experimental gene-therapy treatment for Duchenne muscular dystrophy (DMD) is showing some early signs of promise. Patients who received the therapy are showing increasing signs of a muscle protein that had been missing, the company said.

October 4, 2018
·
3 min read
·
Alex Keown
Business

Leading Pharma Executive Kate Hilyard Joins Healx to Drive the Integration of AI with Drug Discovery for Rare Diseases

Healx today announced the appointment of Kate Hilyard PhD as Chief Operating Officer (COO).

October 4, 2018
·
4 min read
Business

Ingenza extends successful collaboration with Syngenta

Ingenza has announced that its collaboration with Syngenta for work on efficient technologies to support the development of crop protection products has been extended.

October 4, 2018
·
2 min read
Business

MOHAP signs two MoUs with Astrazeneca and Bayer to provide free medicines to patients with critical illnesses

Dr. Amin Al Amiri: the Programs are part of ministry’s initiatives during ‘Year of Zayed’ to provide quality of care to patients

October 4, 2018
·
3 min read
Business

New Non-partisan Group Will Fight to Protect Biopharmaceutical Innovation and Patient Access

The Alliance to Protect Medical Innovation (APMI) will educate the public about medical breakthroughs and fact-check policies that would limit lifesaving cures and treatments

October 4, 2018
·
1 min read
Biotech Beach

Riffyn launches Open Access for scientists at non-profits

Riffyn has launched Riffyn Open Access which provides free use of its patented Scientific Development Environment (SDE™) to any member of a non-profit organization.

October 4, 2018
·
2 min read
Bio NC

Polarean Imaging Plc Delivery of Xenon Polariser

Polarean Imaging plc announces the delivery of the latest model of Polarean’s Xenon polariser to The Department of Radiology at University of Missouri Health Care(“MUHC”).

October 4, 2018
·
1 min read